Table 3.
Model 4 | Model 5 | Model 6 | ||||
---|---|---|---|---|---|---|
HR (95%CI) | P value | HR (95% CI) | P value | HR (95% CI) | P value | |
METS-IR | 1.04 (1.03–1.06) | < 0.001 | 1.04 (1.03–1.06) | < 0.001 | 1.04 (1.03–1.05) | < 0.001 |
< 40.889 | Reference | Reference | Reference | |||
≥ 40.889 | 1.78 (1.54–2.07) | < 0.001 | 1.84 (1.58–2.13) | < 0.001 | 1.62 (1.38–1.89) | < 0.001 |
M1 | Reference | Reference | Reference | |||
M2 | 1.32 (1.08–1.61) | 0.007 | 1.34 (1.10–1.63) | 0.004 | 1.26 (1.02–1.54) | 0.030 |
M3 | 2.05 (1.71–2.47) | < 0.001 | 2.14 (1.77–2.58) | < 0.001 | 1.82 (1.50–2.22) | < 0.001 |
AF, atrial fibrillation; CI, confidence interval; HR, hazard ratio; METS-IR, metabolic score for insulin resistance; M1: METS-IR ≤ 35.585; M2: 35.585 < METS-IR ≤ 40.863; M3: 40.863 < METS-IR
Model 4: Unadjusted
Model 5: Adjusted for age and sex
Model 6: Adjusted for age, sex, current drinking, diabetes mellitus, hyperlipidemia, coronary heart disease, duration of AF (≥ 24 months), AF type, HbA1c, left atrial diameter, platelet, CHA2DS2-VASc score